Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017

In Africa, breast cancer closely compares with cervical cancer as the most common malignancy affecting women and the incidence rates appear to be rising. Eritrea is experiencing a growing breast cancer problem, but little is presently known on tumor patterns, breast cancer epidemiology, and risk fac...

Full description

Saved in:
Bibliographic Details
Main Authors: Lidia B. Medhin, Lia A. Tekle, Daniel T. Fikadu, Danait B. Sibhatu, Samson F. Gebreyohans, Kibrom H. Gebremichael, Tesfamariam M. Halki, Saleh M. Said, Yosief T. Ghidei, Hartmut Lobeck
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2019/8536548
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850106804390854656
author Lidia B. Medhin
Lia A. Tekle
Daniel T. Fikadu
Danait B. Sibhatu
Samson F. Gebreyohans
Kibrom H. Gebremichael
Tesfamariam M. Halki
Saleh M. Said
Yosief T. Ghidei
Hartmut Lobeck
author_facet Lidia B. Medhin
Lia A. Tekle
Daniel T. Fikadu
Danait B. Sibhatu
Samson F. Gebreyohans
Kibrom H. Gebremichael
Tesfamariam M. Halki
Saleh M. Said
Yosief T. Ghidei
Hartmut Lobeck
author_sort Lidia B. Medhin
collection DOAJ
description In Africa, breast cancer closely compares with cervical cancer as the most common malignancy affecting women and the incidence rates appear to be rising. Eritrea is experiencing a growing breast cancer problem, but little is presently known on tumor patterns, breast cancer epidemiology, and risk factors. The main objective of this study is to provide baseline data on breast cancer incidence in both sexes in Eritrea. This study was carried out retrospectively and quantitatively by collecting, abstracting, analyzing, coding, and interpreting data recorded in National Health Laboratory (NHL) using CanReg5 ver. 5.00.35. Extracting and classification of the tumor data was done using topography, morphology together with the ICD-10. To generate the incidence rate for the seven years the Eritrean population dataset was used from the population pyramid net for 2014. After we entered all the data from Pathology department in NHL, data was analyzed using the predetermined and developed built-in analysis tools of CanReg5 software and Microsoft Excel 2010. A total number of 9,403 pathology cases were recorded from 2011 to 2017. Out of these 1,497 cases were confirmed as cytology and histology of breast cases. From 1,497 confirmed breast cases in both sexes, the incidence of benign cases was higher than incidence of malignant cases with the case number of 1, 149, and 348, respectively. Out of the 1,497 cases, 1,447 (96.66%) were females; this included a total incidence cases of female benign and malignant breast cases 1,111 (76.78%), and 336 (23.22%), respectively. In both female and male age group the highest positive cases were found in the age greater than 85. The incidence age standard rate per 100,000 in females and male was 3.3 and 0.2, respectively. In sum, the age standardized incidence of breast cancer was relatively low. However, it is our opinion that the low prevalence may be due to low awareness and a highly centralized screening and diagnostic services. This limits access. Altogether, it is our opinion that breast cancer presents a burden to Eritrean ministry of health.
format Article
id doaj-art-4dc25a95cbb64475b75ea8ec48c8b924
institution OA Journals
issn 2090-3170
2090-3189
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series International Journal of Breast Cancer
spelling doaj-art-4dc25a95cbb64475b75ea8ec48c8b9242025-08-20T02:38:45ZengWileyInternational Journal of Breast Cancer2090-31702090-31892019-01-01201910.1155/2019/85365488536548Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017Lidia B. Medhin0Lia A. Tekle1Daniel T. Fikadu2Danait B. Sibhatu3Samson F. Gebreyohans4Kibrom H. Gebremichael5Tesfamariam M. Halki6Saleh M. Said7Yosief T. Ghidei8Hartmut Lobeck9Pathology, National Health Laboratory, Asmara, EritreaMicrobiology, National Health Laboratory, Asmara, EritreaNational Blood Transfusion Service, Asmara, EritreaMicrobiology, National Health Laboratory, Asmara, EritreaPathology, National Health Laboratory, Asmara, EritreaPathology, National Health Laboratory, Asmara, EritreaPathology, National Health Laboratory, Asmara, EritreaMicrobiology, National Health Laboratory, Asmara, EritreaSurgical, Orotta Referral Hospital, Asmara, EritreaPathology, National Health Laboratory, Asmara, EritreaIn Africa, breast cancer closely compares with cervical cancer as the most common malignancy affecting women and the incidence rates appear to be rising. Eritrea is experiencing a growing breast cancer problem, but little is presently known on tumor patterns, breast cancer epidemiology, and risk factors. The main objective of this study is to provide baseline data on breast cancer incidence in both sexes in Eritrea. This study was carried out retrospectively and quantitatively by collecting, abstracting, analyzing, coding, and interpreting data recorded in National Health Laboratory (NHL) using CanReg5 ver. 5.00.35. Extracting and classification of the tumor data was done using topography, morphology together with the ICD-10. To generate the incidence rate for the seven years the Eritrean population dataset was used from the population pyramid net for 2014. After we entered all the data from Pathology department in NHL, data was analyzed using the predetermined and developed built-in analysis tools of CanReg5 software and Microsoft Excel 2010. A total number of 9,403 pathology cases were recorded from 2011 to 2017. Out of these 1,497 cases were confirmed as cytology and histology of breast cases. From 1,497 confirmed breast cases in both sexes, the incidence of benign cases was higher than incidence of malignant cases with the case number of 1, 149, and 348, respectively. Out of the 1,497 cases, 1,447 (96.66%) were females; this included a total incidence cases of female benign and malignant breast cases 1,111 (76.78%), and 336 (23.22%), respectively. In both female and male age group the highest positive cases were found in the age greater than 85. The incidence age standard rate per 100,000 in females and male was 3.3 and 0.2, respectively. In sum, the age standardized incidence of breast cancer was relatively low. However, it is our opinion that the low prevalence may be due to low awareness and a highly centralized screening and diagnostic services. This limits access. Altogether, it is our opinion that breast cancer presents a burden to Eritrean ministry of health.http://dx.doi.org/10.1155/2019/8536548
spellingShingle Lidia B. Medhin
Lia A. Tekle
Daniel T. Fikadu
Danait B. Sibhatu
Samson F. Gebreyohans
Kibrom H. Gebremichael
Tesfamariam M. Halki
Saleh M. Said
Yosief T. Ghidei
Hartmut Lobeck
Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017
International Journal of Breast Cancer
title Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017
title_full Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017
title_fullStr Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017
title_full_unstemmed Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017
title_short Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017
title_sort incidence of breast cancer in eritrea a retrospective study from 2011 to 2017
url http://dx.doi.org/10.1155/2019/8536548
work_keys_str_mv AT lidiabmedhin incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017
AT liaatekle incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017
AT danieltfikadu incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017
AT danaitbsibhatu incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017
AT samsonfgebreyohans incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017
AT kibromhgebremichael incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017
AT tesfamariammhalki incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017
AT salehmsaid incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017
AT yosieftghidei incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017
AT hartmutlobeck incidenceofbreastcancerineritreaaretrospectivestudyfrom2011to2017